Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Physiological and pathological angiogenesis in the endocrine system.

Miklós I Góth1, Erika Hubina, Stefanos Raptis

  • 1Department of Medicine, National Medical Center, H-1135 Budapest, Hungary. goth@hiete.hu

Microscopy Research and Technique
|December 25, 2002
PubMed
Summary

Angiogenesis, the formation of new blood vessels, is crucial in both normal and cancerous growth. Targeting factors like vascular endothelial growth factor (VEGF) offers new anti-angiogenic therapies for endocrine tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring Vitamin D Trends Through Big Data Analysis.

Nutrients·2025
Same author

Rapid and Sustained Response of Biochemically Uncontrolled Acromegaly to Once-daily Oral Paltusotine Treatment.

The Journal of clinical endocrinology and metabolism·2025
Same author

Comparative Study on Antioxidant Capacity of Diverse Food Matrices: Applicability, Suitability and Inter-Correlation of Multiple Assays to Assess Polyphenol and Antioxidant Status.

Antioxidants (Basel, Switzerland)·2025
Same author

Effects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial.

Nutrients·2025
Same author

Safety and Efficacy of Loading Doses of Vitamin D: Recommendations for Effective Repletion.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Six years' experience and trends of serum 25-hydroxy vitamin D concentration and the effect of vitamin D<sub>3</sub> consumption on these trends.

Frontiers in pharmacology·2023

Area of Science:

  • Endocrinology
  • Oncology
  • Vascular Biology

Background:

  • Angiogenesis, or new blood vessel formation, is vital in embryonic development, reproductive cycles, and pathological conditions like diabetic retinopathy and wound healing.
  • Tumor angiogenesis is linked to tumor formation, prognosis, and treatment response in various cancers.
  • Intratumoral microvessel density correlates with tumor behavior and hormone secretion in endocrine tumors, such as prolactinomas and thyroid carcinomas.

Purpose of the Study:

  • To explore the role of angiogenesis in endocrine tumors.
  • To investigate the potential of targeting angiogenic factors for anti-cancer therapy.
  • To discuss the clinical and experimental aspects of angiogenesis in endocrine system tumors.

Main Methods:

  • Review of existing literature on angiogenesis in physiological and pathological states.

Related Experiment Videos

  • Analysis of the relationship between microvessel density and tumor characteristics in specific endocrine tumors (prolactinomas, thyroid carcinomas).
  • Discussion of the role of vascular endothelial growth factor (VEGF) and its signaling pathways.

    • Main Results:

    • Invasive prolactinomas exhibit higher vascularity than noninvasive adenomas, impacting surgical success.
    • Papillary thyroid carcinomas show increased microvessel counts during recurrence, suggesting a link to prognosis.
    • Vascular endothelial growth factor (VEGF) is a key regulator of tumor neovascularization, and its signaling can be modulated by dopamine agonists and glucocorticoids.

    Conclusions:

    • Dopamine agonists may serve as anti-angiogenic agents for endocrine tumors by inhibiting VEGF signaling.
    • Glucocorticoids, like dexamethasone, can inhibit VEGF secretion in pituitary adenomas, suggesting a therapeutic role.
    • Modulating angiogenic factors holds promise for novel therapeutic strategies in reproductive endocrine disorders and endocrine system tumors.